Institutional
Samsara BioCapital, LLC
CIK 0001744967
$1.03B
Reported AUM
22
Positions
Q1 2026
Period
2026-05-15
Filed
The Brief · Samsara BioCapital, LLC · Q1 2026
AI · grounded in 13F
Samsara BioCapital, LLC established a new position in SGP valued at $54.67M. The fund also opened new stakes in AGMB for $6.29M and CHRS for $5.79M. On the selling side, the fund trimmed its holding in PVLA by 63.33% and closed its position in CTNM, reducing exposure by $825,760.
Portfolio · Q1 2026
Top holdings
QoQ vs Q4 2025
| # | Ticker | Issuer | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|
| 1 | SRRK | SCHOLAR ROCK HLDG CORP | $339.1M | 32.95% | — | HELD |
| 2 | MLYS | MINERALYS THERAPEUTICS INC | $159.0M | 15.45% | — | HELD |
| 3 | ALMS | ALUMIS INC | $139.8M | 13.58% | +588,235 | +10.2% |
| 4 | SEPN | SEPTERNA INC | $75.7M | 7.35% | — | HELD |
| 5 | KLRS | KALARIS THERAPEUTICS INC | $74.7M | 7.26% | — | HELD |
| 6 | SGP | SPYGLASS PHARMA INC | $54.7M | 5.31% | +2,109,953 | NEW |
| 7 | NGNE | NEUROGENE INC | $34.6M | 3.36% | — | HELD |
| 8 | IVA | INVENTIVA SA | $28.8M | 2.80% | — | HELD |
| 9 | STRO | SUTRO BIOPHARMA INC | $26.5M | 2.57% | +858,369 | +419.7% |
| 10 | JBIO | JADE BIOSCIENCES INC | $13.6M | 1.32% | — | HELD |
| 11 | VTVT | VTV THERAPEUTICS INC | $11.8M | 1.15% | — | HELD |
| 12 | AQST | AQUESTIVE THERAPEUTICS INC | $10.4M | 1.01% | — | HELD |
| 13 | XFOR | X4 PHARMACEUTICALS INC | $7.6M | 0.74% | -127,434 | -6.5% |
| 14 | NKTX | NKARTA INC | $7.4M | 0.72% | — | HELD |
| 15 | ACLXGBX | ARCELLX INC | $7.0M | 0.68% | — | HELD |
| 16 | UPB | UPSTREAM BIO INC | $6.6M | 0.64% | — | HELD |
| 17 | ABVX | ABIVAX SA | $6.3M | 0.61% | -18,861 | -25.0% |
| 18 | AGMB | AGOMAB THERAPEUTICS NV | $6.3M | 0.61% | +600,000 | NEW |
| 19 | RANI | RANI THERAPEUTICS HLDGS INC | $6.2M | 0.61% | — | HELD |
| 20 | CHRS | COHERUS ONCOLOGY INC | $5.8M | 0.56% | +3,428,571 | NEW |
| 21 | PVLA | PALVELLA THERAPEUTICS INC NE | $4.8M | 0.47% | -66,385 | -63.3% |
| 22 | GOSS | GOSSAMER BIO INC | $2.4M | 0.23% | — | HELD |
| 23 | CTNM | CONTINEUM THERAPEUTICS INC | — | — | -72,245 | EXITED |
| 24 | NUVB/WS | NUVATION BIO INC | — | — | -124,119 | EXITED |
Source: SEC EDGAR · accession 0001744967-26-000005. 13F discloses long positions only — shorts, foreign equities, and options are excluded.